Search
-
-
Public Notices
Please review our new guidelines for vendors.
… All vendors and contractors — including those with MSK-issued ID badges — are required to follow https://www.mskcc.org/locations/visiting-us/policy-visitors-patients MSK’s Visitor Policy . Any vendor or short-term contractor feeling sick must stay home. Our patients have weakened immune systems and we
-
Public Notices
Revise las nuevas pautas para proveedores.
… Todos los proveedores y contratistas, incluso aquellos con insignias de identificación emitidas por MSK, deben seguir la https://www.mskcc.org/locations/visiting-us/policy-visitors-patients Política de acompañantes de MSK . Los proveedores o contratistas que se sientan enfermos deben quedarse en casa
-
Public Notices
Ознакомьтесь с нашими новыми рекомендациями для поставщиков.
… Все поставщики и подрядчики, включая обладателей выданных центром MSK удостоверений личности, должны соблюдать https://www.mskcc.org/locations/visiting-us/policy-visitors-patients правила посещения, принятые в центре MSK . Любой поставщик или подрядчик, чувствующий недомогание, должен оставаться дома
-
Public Notices
請查看我們為供應商人員制定的新指引。
… 所有供應商人員和承辦工人(包括擁有 MSK 簽發身分證章的相關人士)都必須遵守 https://www.mskcc.org/locations/visiting-us/policy-visitors-patients MSK 訪客政策 。 如感到不適,供應商人員或短期承辦工人 必須留在家中。 我們的患者免疫系統較弱,必須採取一切預防措施,以保護他們免受感染,包括 COVID-19。 如您對訪客政策有任何疑問,請諮詢您通常聯絡的 MSK 單位。 更新日期:2023 年 10 月 2 日
-
Video
Emily Feld is a medical oncologist who sees patients at MSK Commack. She specializes in treating genitourinary cancers, which include prostate, bladder, kidney, and testicular cancers.
… Emily Feld is a medical oncologist who sees patients at MSK Commack. She specializes in treating genitourinary cancers, which include prostate, bladder, kidney, and testicular cancers. How have you been? What I love about my practice is the time I get to spend with my patients — making treatment decisions
-
News
A dynamic mix of experts in biology, chemistry, and medicine come together in the Sloan Kettering Institute lab of chemical biologist Gabriella Chiosis to investigate chaperone proteins involved in cancer.
… Thursday, December 1, 2011 Summary A dynamic mix of experts in biology, chemistry, and medicine come together in the Sloan Kettering Institute lab of chemical biologist Gabriella Chiosis to investigate chaperone proteins involved in cancer. “I’ve always been driven by the hope of discovering something
-
Interventional RadiologistI have been practicing interventional radiology since 1998, and joined the division of interventional radiology and image guided therapies at Memorial Sloan Kettering Cancer Center in 2002. As an expert in interventional oncology, I use minimally invasive procedures performed with image guidance to diagnose and treat cancer patients with minimal side effects, complications, and discomfort.
… Interventional Radiologist Job Title Attending Radiologist I am an interventional radiologist specializing in interventional oncology, caring for people with cancer. I have been practicing interventional radiology since 1998 and joined the Interventional Radiology Service at Memorial Sloan Kettering
-
Interventional RadiologistMe dedico a la radiología intervencionista desde 1998 y me incorporé a la división de radiología intervencionista y terapias guiadas por imágenes del Memorial Sloan Kettering Cancer Center en 2002. Como experto en oncología intervencionista, uso procedimientos de invasión mínima que se realizan con tecnología guiada por imágenes para el diagnóstico y el tratamiento de pacientes con cáncer. Estos procedimientos tienen efectos secundarios mínimos, pocas complicaciones y, prácticamente, no causan inconveniencias.
… Interventional Radiologist Job Title Radiólogo adjunto Soy radiólogo intervencionista especializado en oncología intervencionista al cuidado de personas con cáncer. Me dedico a la radiología intervencionista desde el año 1998 y me incorporé al Servicio de Radiología Intervencionista del Memorial Sloan
-
Clinical Trial
… Full Title A Phase 1/2 Study to Evaluate STK-012 as a Single Agent and in Combination Therapy in Subjects with Front-line Advanced NSCLC and Other Selected Indications Purpose The purpose of this study is to find the highest dose of the investigational drug STK-012 that can be given safely in combination